| Caroline VH, Annick C. Comparison of the fetal fibronectin (rapid FFN) and placental alpha microglobulin-1 (partosure) tests for predicting imminent spontaneous preterm birth in patients with threatened preterm labor. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Desjardins PR, Dansereau J, Hoag GN. Comparing the clinical effectiveness of Fetal Fibronectin and IGFBP-1 measurements in cervico-vaginal secretions, in predicting preterm deliveries. Clinical Chemistry 2008;54:A39–40 | Abstract |
| Ehsanipoor RM, Swank M, Jwa SC, Wing DA, Tarabulsi G, Blakemore KJ. Placental alpha-microglobulin-1 in vaginal secretions as a predictor of preterm birth in women with evidence of preterm labor. Reprod Sci 2014;1:155A | Abstract |
| Fatkullin I, Akhmetgaliev A, Matveeva E, Seeger S. Utilization of a novel biomarker test (PARTOSURE PAMG-1) to reduce the length of stay in patients with threatened preterm labor and a short cervix. J Matern Fetal Neonatal Med 2016;29:283 | Abstract |
| Grobman W, Welshman E, Calhoun E. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol 2002;187(Suppl. 6):S80 | Abstract |
| Grobman WA, Welshman EE, Calhoun EA, Ramsey PS. Fetal fibronectin results did not reduce medical resource use for women with preterm uterine contractions. Evidence-based Obstetrics and Gynecology 2005;7:118–9 | Abstract |
| Hansen W, Lowe M, Zimmerman B. Effect of the fetal fibronectin assay on preterm labor management. Am J Obstet Gynecol 2001;185(Suppl. 6):S136. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/596/CN-00387596/frame.html (accessed September 2017) | Abstract |
| Heverhagen A. Placental alphamicroglobulin-1 in combination with transvaginal ultrasound for prediction of preterm birth. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Heverhagen A, Baumann M, Raio L, Surbek D. Placental alpha-microglobulin-1 in combination with transvaginal ultrasound for prediction of preterm birth. Am J Obstet Gynecol 2015;212(Suppl. 1):S81 | Abstract |
| Heverhagen A, Muller M, Schleussner E, Deruelle P, Raio L, Surbek D. The prediction of preterm birth using placental alpha-microglobulin-1 in combination with transvaginal ultrasound. Reprod Sci 2016;1:131A–2A | Abstract |
| Hillman-Cooper C, Ghag K, Dempsey A, Denbow M, Lopez Bernal A. Actim Partus-the first year at St. Michael’s Hospital, Bristol. Arch Dis Child Fetal Neonatal Ed 2014;99:A158–9 | Abstract |
| Holmgren C, Lacoursiere DY, Esplin MS. Clinical predictors of a false negative fetal fibronectin (FFN). Am J Obstet Gynecol 2007;197:S204-S | Abstract |
| Kang JH, Lee SE, Park C-W, Jun JK, Romero R, Yoon BH. Cervical fetal fibronectin: An index of intra-amniotic inflammation, histologic chorioamnionitis and impending preterm delivery in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2007;197(Suppl. 6):S47 | Abstract |
| Karunakaran B, Berry J, Parasuraman R. Can we raise the threshold for negative fetal fibronectin result? Arch Dis Child Fetal Neonatal Ed 2012;97:A89 | Abstract |
| Konoplyannikov A, Lysyuk I, Sokolyan A, Pipia N, Apresyan S, Karasova A. PAMG-1 biomarker test (PARTOSURE) in combination with transvaginal ultrasound for improved assessment of spontaneous preterm birth in patients with threatened preterm labor. J Matern Fetal Neonatal Med Conference: 25th European Congress of Perinatal Medicine, the Netherlands 2016;29:278. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/387/CN-01214387/frame.html (accessed September 2017) | Abstract |
| Kuhnert M. Individual management of preterm labour by using rapid fetal fibronectintesta. J Matern Fetal Neonatal Med 2014;27:392–3 | Abstract |
| Kung RWK, Northridge R, Nicoll AE. Fetal fibronectin (FFN) and iatrogenic pre-term birth. Arch Dis Child Fetal Neonatal Ed 2012;97:A80–1 | Abstract |
| Lawin-O’Brien A, Jesner O, Biswas C. Evaluation of fetal fibronectin testing, subsequent management and outcomes in a London teaching hospital. Arch Dis Child Fetal Neonatal Ed 2014;99:A119 | Abstract |
| Lega MH. Prediction of preterm delivery in patients in preterm labor. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Lotfi G, Faraz S, Al Swalhee N, Nasir R, Somini S, Abdeldayem R, et al. Evaluation of PAMG-1 for the prediction of preterm birth in patients symptomatic of preterm labor. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Lou YY, Ajay B. Is PartoSure effective in assessing preterm birth? BJOG 2016;123:89 | Abstract |
| Mahavarker S, Osman MW, Ten-Hof J. Phosphorylated insulin-like growth factor binding protein-1 (ACTIM PARTUS) testing in management of threatened preterm labour. Arch Dis Child Fetal Neonatal Ed 2012;97:A99–100 | Abstract |
| Nikolova N, Nikolova T, Jovchevski S, Micevska M. Phosphorylated insulin-like growth factor binding protein-1 in the prediction of preterm delivery in patients with preterm labor. J Matern Fetal Neonatal Med 2016;29:56 | Abstract |
| Nikolova N, Nikolova T, Jovchevski S, Micevska M, Nikolovski S. A comparison between the phosphorylated insulin-like growth factor binding protein-1 and the cervical length in prediction of sampling to delivery time in patients with preterm labor. J Matern Fetal Neonatal Med 2016;29:56 | Abstract |
| Nikolova T, Uotila J, Nikolova N, Borisova V, Bolotskikh V. Do PAMG-1 or phIGFBP-1 biomarkers improve the prediction of imminent spontaneous preterm delivery in PTL symptomatic women with non-obvious cervical length (CL)? Am J Obstet Gynecol Conference: 37th annual meeting of the society for maternal-fetal medicine: the pregnancy meeting United States 2017;216(Suppl. 1):S11–2. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/156/CN-01304156/frame.html (accessed September 2017) | Abstract |
| Northridge R, Liu H, Youssef R, Nicoll AE. Predicting pre-term birth using fetal fibronectin (FFN) in Ninewells Hospital, Dundee. Arch Dis Child Fetal Neonatal Ed 2011;96:Fa69 | Abstract |
| Ponnusamy V, Farrer K. Impact of antenatal tests on acute in-utero transfers. Arch Dis Child Fetal Neonatal Ed 2012;97:A87 | Abstract |
| Radford S, Costa F, Junior E, Sheehan P. Clinical application of quantitative fetal fibronectin for the prediction of preterm birth in symptomatic women. BJOG: Conference: RCOG World Congress 2016, UK 2016;123:158–9. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/043/CN-01179043/frame.html (accessed September 2017) | Abstract |
| Randhawa TS, Kwek K. Assessment of the predictive value of phosphorylated insulinlike growth factor binding protein-1 for preterm delivery. J Matern Fetal Neonatal Med 2010;23:294 | Abstract |
| Spyroulis C, Tsitlakidis C. Prospective study of the Actim Partus test to predict preterm delivery between 24–34 weeks of gestation in Glan Clwyd Hospital. Period of study between August 2014–February 2015. BJOG 2016;123:8 | Abstract |
| Thandayathany V, Yassin MAJM, Omar MH, Ismail NAM, Tamil AM, Kampan NC. Fetal fibronectin rapid test versus phosphorylated insulin-like growth factor-1 (phIGFBP-1) as bedside test kits for prediction of preterm delivery in the clinical setting. BJOG 2012;119:5 | Abstract |
| Van Holsbeke C, Dam K, Staelens A, Mesens T, Corremans A. OP11.04: Comparison of the fetal fibronectin (Rapid fFN) and placental alpha microglobulin-1 (PartoSure) tests for predicting imminent spontaneous preterm birth. Ultrasound Obstet Gynecol 2016;48:84 | Abstract |
| Sophie W, Tiphaine B, Celine C, Aurelie DB. Preterm labor: Reliability of the partosure test before and after digital and transvaginal ultrasound examinations. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Bare T, Mitre A, Shahinaj R, Bakiri F. Fetal fibronectin and cericometry in patients at increased risk for premature birth. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Abstract |
| Benson J, Ghidini A, Landy H, Gilo N, Drassinower D, Poggi S. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage. Am J Obstet Gynecol 2009;201:S68–S9 | Abstract |
| Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008;4:CD006843. https://doi.org/10.1002/14651858.CD006843.pub2 | Abstract |
| Burrus DR, Ernest JM, Veille JC. Efficacy of four markers of preterm labor (PTL) at predicting preterm delivery (PTD) in a population presenting with contractions and cervical change. Am J Obstet Gynecol 1995;172:405 | Abstract |
| Burrus DR, Ernest JM, Veille JC. Efficacy of four markers of preterm labor (PTL) at predicting latency (LAT) in a population receiving tocolytic therapy. Am J Obstet Gynecol 1995;172:405 | Abstract |
| Goepfert AR, Network NM. The preterm prediction study: Quantitative fetal fibronectin (FFN) values and the prediction of spontaneous preterm birth (SPTB). Am J Obstet Gynecol 1997;176:S52 | Abstract |
| Goldenberg RL. Vaginal fetal fibronectin (V-fFN) levels at 8–22 weeks and subsequent spontaneous preterm birth (SPB). Am J Obstet Gynecol 2000;182:S32 | Abstract |
| Greenhagen JB, Van Wagoner J, Dudley D, Hunter C, Mitchell M, Casal D, et al. The value of fetal fibronectin as a predictor of preterm delivery in low risk women. Am J Obstet Gynecol 1996;174:471 | Abstract |
| Grover CM. Use of the fetal fibronectin assay to avert unnecessary hospitalization and bedrest in patients with preterm labor symptoms: a cost analysis. Prim Care Update Ob Gyns 1998;5:178–9 | Abstract |
| Hadzi-Lega M, Daneva Markova A, Micevska M, Atanasovska Bosku A, Gjirevski V. Cervical length and phosphorilated insulin like growth factor binding protein-1 as a predictors of spontaneus preterm delivery in symptomatic women. J Matern Fetal Neonatal Med 2014;27:399 | Abstract |
| Hedriana HL, Bliss MC, Gilbert WM. Implementation of fetal fibronectin (FFN) testing in a large private practice hospital is safe and effective for the diagnosis and management of preterm labor (PTL). Am J Obstet Gynecol 2005;193:S52-S | Abstract |
| Henrich W. Cervicometry and fibronectin role. J Matern Fetal Neonatal Med 2010;23:39 | Abstract |
| Hillman-Cooper C, Denbow M, Lopez Bernal A. Identification and quantification of maternal plasma proteins that predict preterm labour. BJOG 2013;120:160–1 | Abstract |
| Hillman-Cooper CS, Denbow M, Bernal AL. Identification and quantification of maternal plasma proteins that predict preterm labour. Endocrine Reviews Conference: 95th Annual Meeting and Expo of the Endocrine Society, ENDO 2013;34(Suppl. 1) | Abstract |
| Hong J-S, Yoon BH, Romero R, Shim S-S, Sohn Y-K, Park C-W, et al. Patients with a positive cervical fetal fibronectin followed by a negative test have a reduced likelihood of spontaneous preterm delivery. Am J Obstet Gynecol 2003;189(Suppl. 6):S173 | Abstract |
| Iriye B, Hancock J, Wold S, Huang W, Gorski L, Hancock L. Fetal fibronectin (fFN) testing in symptomatic patients for preterm labor and McDonald cerclage. Am J Obstet Gynecol 2004;191:S111-S | Abstract |
| Joffe G. The use & cost benefit of fetal fibronectin testing in an integrated health care system. Clinical Chemistry 1999;45:S32–S3 | Abstract |
| Kay S, McKie L, Ajoku K, Roberts N. Fetal fibronectin testing in a district general hospital setting – Are we changing our management of women with symptomatic preterm labour? BJOG 2015;122:186 | Abstract |
| Khizar SBK, Vallabu S. How to introduce a new service in clinical practice. BJOG 2013;120:96 | Abstract |
| Kiefer D, Keeler S, Rust O, Demishev M, Muscat J, Bornstein E, et al. Is fetal fibronectin (FFN) a marker of intra-amniotic inflammation in patients with midtrimester short cervix? Am J Obstet Gynecol 2009;201:S60-S | Abstract |
| Knee A, Belisle E, Markenson G, Malshe A, Plevyak M, Bsat F, et al. Do pregnancies complicated by preterm births with a negative fetal fibronectin screen have different characteristics compared to those that have positive fibronectin results? Am J Obstet Gynecol 2011;204:S190-S | Abstract |
| Knight B, Smith H, Tregarthen A, Lapointe J, Shennan A, Taylor MJO, et al. Quantitative fetal fibronectin as a predictor of time to delivery in women undergoing induction of labour: a pilot study. BJOG 2016;123:E5-E | Abstract |
| Kreaden U, Sheldon L, Lockhart T, Paulson M, Shorter S, Martinez R, et al. Natural distribution of fetal fibronectin (fFN) among symptomatic and asymptomatic pregnant women. Clinical Chemistry 1999;45:A86–7 | Abstract |
| Krems J, McGregor J, Hastings C, Hanson J. Fetal fibronectin in cervical secretions: An aid for predicting delivery in women at high risk from preterm delivery. Am J Obstet Gynecol 1995;172:406 | Abstract |
| Kuhrt K, Seed P, Smout E, Hezelgrave N, Shennan A. The development and validation of a new tool to predict spontaneous preterm birth in high-risk women using quantitative fetal fibronectin and cervical length. BJOG 2013;120:14–15 | Abstract |
| Kurtzman J, Chandiramani M, Riley A, Poston L, Das A, Shennan A. Quantitative fetal fibronectin screening at 24 weeks delineates the risk of spontaneous preterm delivery in asymptomatic patients with a prior history of preterm premature rupture of membranes (PPROM). Am J Obstet Gynecol 2009;1:S227 | Abstract |
| Kurtzman J, Jimenez-Solis G, Rosalesortiz S, Martinez-Alvarez O, Das A, Antonio AMJ. Cervical length significantly modifies the risk of preterm delivery in low risk patients with symptomatic preterm labor and a positive fetal fibronectin. Am J Obstet Gynecol 2008;199:S212-S | Abstract |
| Levine LD, Romero JA, Pappas H, Weber AL, Elovitz MA. A prospective blinded cohort study evaluating fetal fibronectin and cervical length in predicting preterm birth in symptomatic women. Am J Obstet Gynecol 2016;214:S441–2 | Abstract |
| Luzzi V, Hankins K, Gronowski AM. Accuracy of the rapid fetal fibronectin TLi system in predicting preterm delivery. Clin Chem 2003;49:501–2 | Abstract |
| Maharajan P, Elliot J, Thampi P. Efficacy of fibronectin and its impact on the use of atosiban-cost implication. Arch Dis Child Fetal Neonatal Ed 2012;97:A92 | Abstract |
| Mancuso M, Biggio J, Owen J. Fetal fibronectin and latency period in women with arrested preterm labor. Am J Obstet Gynecol 2013;208:S221-S | Abstract |
| Mateus J, Pereira L, Baxter J, Berghella V, Cheku B, Tolosa JE. Fetal fibronectin compared to cervical dilation in clinical practice. Am J Obstet Gynecol 2003;189:S165-S | Abstract |
| McKenna DS, Chung K, Shubert P, Iams JD. The effect of digital examination on the expression of fetal fibronectin. Am J Obstet Gynecol 1998;178:S188 | Abstract |
| Merriam A, Sciscione A, Daniel L. A prospective evaluation of the effectiveness of vaginal fetal fibronectin to predict preterm birth in women with symptoms of preterm labor in the outpatient setting. Am J Obstet Gynecol 2014;210:S224-S | Abstract |
| Mogami H, Kondo E, Fujita K, Chigusa Y, Nishimura F, Ujita M, et al. Fetal fibronectin is a pathogenic factor of preterm PROM and preterm birth. Placenta 2013;34:A4-A | Abstract |
| Morrison JC, Naefi RWI, Botti JJ, Katz M, Belluomini JM. Uterine activity and fetal fibronectin are independent and combined predictors of spontaneous preterm birth. Am J Obstet Gynecol 1995;172:406 | Abstract |
| Muller A, McCullough M, Obican S, Norton H, Carter J, Gonzalez-Quintero VH. ‘false’ positive fetal fibronectin and rates of adverse obstetrical outcomes. Am J Obstet Gynecol 2006;195:S233-S | Abstract |
| Muzaffar S, Behrens R, Barns F, Walker S. Quantitative fetal fibronectin and preterm delivery. BJOG 2013;120:595–6 | Abstract |
| Myint H, Singh V, Roberts NJ. Introducing fetal fibronectin testing to a District General Hospital in women with symptoms of preterm labour. Arch Dis Child Fetal Neonatal Ed 2011;96:Fa83 | Abstract |
| Myint HH, Ciopec A, Roberts N, Sinha P. Use of fetal fibronectin testing in a district general hospital in women with symptoms of preterm labour. BJOG 2013;120:41–2 | Abstract |
| Ness A, Airoldi J, Modena A, Baxter J, Berghella V. Triage of women with possible preterm labor using transvaginal ultrasound cervical length and fetal fibronectin. Am J Obstet Gynecol 2005;193:S58-S | Abstract |
| O’Brien J, Mercer B, Pitts DW, Sibai BM. A comparison of fetal fibronectin, prolactin, and cervical examination for the prediction of preterm delivery in symptomatic patients. Am J Obstet Gynecol 1995;172:406 | Abstract |
| O’Byrne L, Daly S. Audit of fetal fibronectin use in a tertiary referral hospital in the triaging of threatened preterm labour. BJOG 2016;123:13–14 | Abstract |
| Osorio M, Neiva R, Montes L, Silva J, Pinelo S, Pinho M, et al.
The Impact of Fetal Fibronectin Assay on Preterm Labor Management: A Randomized Controlled Trial. In Puertas A, Montoya F, Romero J, Hurtado J, Manzanares S, editors. Granada: European Congress, Advances in Perinatal Medicine; 2010 | Abstract |
| Osorio M, Neiva R, Montes L, Silva J, Pinelo S, Pinho M, et al. The impact of fetal fibronectin assay on preterm labor management: A randomized controlled trial. J Matern Fetal Neonatal Med 2010;23:304–5 | Abstract |
| Peaceman AM, Andrews WW, Thorp JM, Cliver SP, Lukes A, Group FFS. Fetal fibronectin as a predictor of preterm birth in symptomatic patients: A multicenter trial. Am J Obstet Gynecol 1996;174:303 | Abstract |
| Pilpel S, Markenson G, Hoffman D. A comparison of fetal fibronectin testing in predicting preterm birth in twin verses singleton gestations. Am J Obstet Gynecol 2002;187(Suppl. 6):S120 | Abstract |
| Pradhan-Drews M, Drews F, Goddard R. Audit on preterm labour. BJOG 2013;120:431–2 | Abstract |
| Radford S, Abbott D, Seed P, Kemp J, Shennan A. Quantitative fetal fibronectin for the prediction of preterm birth in symptomatic women. Arch Dis Child Fetal Neonatal Ed 2012;97:A73 | Abstract |
| Radford S, Smith J, Shennan A, Wallace EM. Interhospital transfers of women in threatened preterm labour to Victorian level 6 hospitals. J Paediatr Child Health 2015;51:51 | Abstract |
| Ray D, Dyson D. Fetal fibronectin as a predictor of preterm delivery in symptomatic patients. Am J Obstet Gynecol 2001;184:S37 | Abstract |
| Rebarber A, Sfakianaki AK, Kuczynski E, Paidas M, Russo K, Maturi J, et al. Fetal fibronectin is a valid predictor of spontaneous preterm delivery in patients with cervical cerclages. Am J Obstet Gynecol 2001;185(Suppl. 6):S128 | Abstract |
| Revah A, Sue-A-Quan A, Hannah M. Fetal fibronectin as a predictor of preterm birth: A systematic review of the literature. Am J Obstet Gynecol 1997;176:S53 | Abstract |
| Richards KM, Troeger KA, Petrilla A, Agatep B, Johnsrud M, Blackwell SC. Burden of preterm labor in the texas medicaid population. Value in Health 2016;19:A178 | Abstract |
| Rizzo G, Capponi A, Arduini D, Romanini C. The prognostic value of interleukin-8 and fetal fibronectin concentrations in cervical secretions in patients with preterm labor. Am J Obstet Gynecol 1997;176:S6 | Abstract |
| Roman AS, Koklanaris N, Roshan D, Paidas M, Mulholland J, Levitz M, et al. ‘Blind’ vaginal fetal fibronectin as a predictor of spontaneous preterm delivery: A novel sampling technique. J Soc Gynecol Investig 2004;11:204A–5A | Abstract |
| Rosenblatt KP, Nicolaides KH, Romero R, Bryant-Greenwood PK, Syngelaki A, Menon R, et al. Proteomic derived biomarker panel for first trimester identification of patients at risk for pre-term delivery. Reprod Sci 2013;1:80A | Abstract |
| Salari K, Treadwell M, Thompson K. Predictors of preterm birth: a comparison of cervical length, fetal fibronectin and fetal adrenal gland enlargement. Am J Obstet Gynecol 2015;212:S179–80 | Abstract |
| Sasson I, Triche EW, Azpurua H, Romano M, Paidas M. Short cervix and negative fetal fibronectin: low risk of delivery within 2 weeks of screening. Am J Obstet Gynecol 2008;199:S49-S | Abstract |
| Schmiedel D, Fischer T, Von Tucher E, Henrich W, Slowinski T, Thomas A. Combination of cervical sonoelastography with cervical length measurement and fetal fibronectin to improve prediction of preterm birth. Ultraschall in der Medizin, Supplement Conference: Ultraschall 2013;34(no pagination) | Abstract |
| Simhan H. Comparison of self-collected vs speculum-collected measurement of quantitative fetal fibronectin. Am J Obstet Gynecol 2016;214:S310–1 | Abstract |
| Stern V, Amabebe E, Anumba D. The association between cervicovaginal fetal fibronectin, the metabolic markers of the vaginal microbiome, and preterm birth. BJOG 2016;123:79–80 | Abstract |
| Stern V, Anumba D. Screening for preterm birth with serial cervical length measurement and fetal fibronectin quantification – does rate of change predict early delivery? BJOG 2016;123:80 | Abstract |
| Stern V, Anumba DOC. Predicting preterm birth – the performance of ultrasound cervical length, quantitative fetal fibronectin and vaginal fluid pH differs by risk of preterm birth and symptoms of preterm labour. Reprod Sci 2016;23:106A-A | Abstract |
| Stern V, Healey J, Brown B, Anumba D. Assessing the risk of spontaneous premature birth by electrical impedance spectroscopy of the cervix: The ecclippx study. Reprod Sci 2015;22:331A | Abstract |
| Stern V, Healey J, Jones G, Dixon S, Walters S, Brown B, et al. The ECCLIPPx study: Electrical impedance prediction of preterm birth. Arch Dis Child Fetal Neonatal Ed 2014;99:A113–6 | Abstract |
| Swamy G, Simhan H, Seglin H, Heine P. The clinical utility of fetal fibronectin. Am J Obstet Gynecol 2001;185(Suppl. 6):S136 | Abstract |
| Swancoat S. ‘Recent vaginal exam’ no longer a contraindication to fetal fibronectin sampling: A prospective study. Obstetrics and Gynecology 2016;127:16S-S | Abstract |
| Thompson KG, Vaillancourt C, Moore S. Air medical transfer of patients in preterm labour: current treatments and tocolytics provided in Ontario. Canadian Journal of Emergency Medicine 2013;15:S6 | Abstract |
| Turitz AL, Ananth C, Gyamfi-Bannerman C. A comparison of quantitative pre- and post-vaginal manipulation fetal fibronectin. Am J Obstet Gynecol 2017;216(Suppl. 1):S197 | Abstract |
| van Baaren GJ, Bruijn M, Vis J, Wilms F, Oudijk M, Kwee A, et al. False-positive, false-negative and uninterpretable results in fetal fibronectin testing during the APOSTEL1 study; which factors do contribute? Am J Obstet Gynecol 2014;210:S395-S | Abstract |
| van der Krogt L, Hezelgrave N, Seed P, Shennan A. Prediction of spontaneous preterm birth using fetal fibronectin in women with a low-lying placenta. BJOG 2016;123:85 | Abstract |
| Vanner T, Rooney M, Blackburn S. Trends in In-utero transfer: Royal Wolverhampton Hospitals NHS Trust 2007 to 2010. Arch Dis Child Fetal Neonatal Ed 2011;96:Fa38 | Abstract |
| Watson H, Carter J, Tribe RM, Shennan AH. The QUIPP app: A safe alternative to a treat-all strategy for threatened preterm labour. BJOG 2017;124:30–1 | Abstract |
| Watson HA, Ridout A, Ross G, Shennan AH. Decision-making about preterm birth using the QUIPP app: A survey of women’s experiences. BJOG 2017;124:132 | Abstract |
| Akercan F, Cirpan T, Kazandi M, Terek MC, Mgoyi L, Ozkinay E. The value of the insulin-like growth factor binding protein-1 in the cervical-vaginal secretion detected by immunochromatographic dipstick test in the prediction of delivery in women with clinically unconfirmed preterm premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2005;121:159–63 | Comparator |
| Akercan F, Kazandi M, Sendag F, Cirpan T, Mgoyi L, Terek MC, Sagol S. Value of cervical phosphorylated insulinlike growth factor binding protein-1 in the prediction of preterm labor. J Reprod Med 2004;49:368–72 | Comparator |
| Gibson S, Hezelgrave NL, Shennan AH. The impact of quantitative fetal fibronectin on the clinical management of women symptomatic of preterm labour. Arch Dis Child Fetal Neonatal Ed 2014;99:A151–5 | Comparator |
| Kuhrt K, Hezelgrave N, Foster C, Seed PT, Shennan AH. Development and validation of a tool incorporating quantitative fetal fibronectin to predict spontaneous preterm birth in symptomatic women. Ultrasound Obstet Gynecol 2016;47:210–16. https://doi.org/10.1002/uog.14894 | Comparator |
| Honest H, Bachmann LM, Gupta JK, Kleijnen J, Khan KS. Cervicovaginal fetal fibronectin test for predicting risk of spontaneous preterm birth. ACOG Clinical Review 2002;7:3–4 | Design |
| ACOG Committee. Management of preterm labor. Int J Gynaecol Obstet 2003;82:127–35 | Design |
| Burwick R, Zork N, Lee G, Ross M, Kjos S. Cervilenz assessment of cervical length compared to fetal fibronectinin the prediction of preterm delivery in women with threatened preterm labor. J Matern Fetal Med 2011;24:127–31. https://doi.org/10.3109/14767058.2010.529201. [Erratum published in J Matern Fetal Med 2016;29:3212.] | Design |
| Abbott D, Radford S, Foster C, Vousden N, Shennan A. Longitudinal trend of quantitative fetal fibronectin in the prediction of delivery following insertion of a rescue cerclage. J Obstet Gynaecol 2013;33:414–15. https://doi.org/10.3109/01443615.2013.772129 | Design |
| Adams TM, Kinzler WL, Chavez MR, Fazzari MJ, Vintzileos AM. Practice patterns in the timing of antenatal corticosteroids for fetal lung maturity. J Matern Fetal Neonatal Med 2015;28:1598–601. https://doi.org/10.3109/14767058.2014.962508 | Design |
| Afify E, Pasupathy D, Briley A, Seed P, Poston L, Shennan A. The effect of maternal obesity on preterm delivery in a high risk cohort. Am J Obstet Gynecol 2011;204(Suppl. 1):S224 | Design |
| Barnard EP. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: A systematic review and metaanalysis of randomized controlled trials. Obstetrics and Gynecology 2016;128:404 | Design |
| Bernhardt J, Dorman K. Pre-term birth risk assessment tools. Exploring fetal fibronectin and cervical length for validating risk. AWHONN Lifelines 2004;8:38–44 | Design |
| Brink S, Chetwynd J, Mannix M. A telling test for early birth . . . use of a vaginal smear to detect fetal fibronectin. US News & World Report 1995;119:86 | Design |
| Bruijn MMC, Hermans FJR, Vis JY, Wilms FF, Oudijk MA, Kwee A, et al. Which factors contribute to false-positive, false-negative, and invalid results in fetal fibronectin testing in women with symptoms of preterm labor? Am J Perinatol 2017;34:234–9 | Design |
| Chandiramani M, Di Renzo GC, Gottschalk E, Helmer H, Henrich W, Hoesli I, et al. Fetal fibronectin as a predictor of spontaneous preterm birth: a European perspective. J Matern Fetal Neonatal Med 2011;24:330–6. https://doi.org/10.3109/14767058.2010.496879 | Design |
| Chien PFW, Khan KS, Ogston S, Owen P. How useful is cervico-vaginal fetal fibronectin in predicting preterm labour – Evidence from an overview. J Obstet Gynecol 1998;18:95 | Design |
| Colombo DF. Predicting spontaneous preterm birth – Fetal fibronectin and ultrasonography help to rule out labour, not rule it in. BMJ 2002;325:289–90 | Design |
| Crawshaw SE, Briley AL. Clinical. A new strategy to tackle preterm labour: PREMET trial. RCM Midwives Journal 1999;2:122–4 | Design |
| Daskalakis GJ, Papantoniou NE, Koutsodimas NB, Papapanagiotou A, Antsaklis AJ. Fetal fibronectin as a predictor of preterm birth. J Obstet Gynaecol 2000;20:347–53 | Design |
| Decimoni TC, Sansone D, Etto H, Santos AM, Araujo G, Fonseca ES, et al. Systematic literature review and cost-effectiveness analysis of fetal fibronectin test for predicting preterm in Brazil. Value Health 2013;16:A333–4 | Design |
| Deshpande S, Asselt A, Tomini F, Armstrong N, Allen A, Noake C, et al. Rapid fetal fibronectin (fFN) testing to predict pre-term birth in women with symptoms of premature labour: A systematic review and cost-effectiveness analysis. Health Technol Assess 2013;17(4). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32012000531/frame.html (accessed September 2017) | Design |
| Elliott JP, Miller HS, Coleman S, Rhea D, Abril D, Hallbauer K, et al. A randomized multicenter study to determine the efficacy of activity restriction for preterm labor management in patients testing negative for fetal fibronectin. J Perinatol 2005;25:626–30 | Design |
| Evantash E. Vaginal Fetal Fibronectin to Predict Spontaneous Preterm Birth. JAMA 2017;318:198–9. https://doi.org/10.1001/jama.2017.7133 | Design |
| Faron G, Boulvain M, Irion O. Fetal fibronectin for prediction of preterm delivery: A meta-analysis. Am J Obstet Gynecol 1996;174:471 | Design |
| Feinberg RF, Kliman HJ. Fetal fibronectin and preterm labor. N Engl J Med 1992;326:708. https://doi.org/10.1056/NEJM199203053261013 | Design |
| French L. Fetal fibronectin to predict preterm delivery. J Fam Pract 1998;47:250–1 | Design |
| Fuks B, Petrunin DD, Zaraisky EI, Boltovskaya MN, Nazimova SV, Starosvetskaya NA, et al., inventors Devices and methods for detecting amniotic fluid in vaginal secretions patent US 08114610. 2012 Feb 14 2012 | Design |
| Fuks B, Petrunin DD, Zaraisky EIi, Boltovskaya MN, Nazimova SV, Starosvetskaya NA, et al., inventors Devices and methods for detecting amniotic fluid in vaginal secretions patent US 09568479. 2017 Feb 14 2017 | Design |
| Gebhardt S, Odendaal HJ. Fetal fibronectin in vaginal secretions – a predictor of preterm delivery? S Afr Med J 1995;85:188 | Design |
| Goldenberg RL, Andrews WW, Hauth JC. Markers of preterm birth. Prenat Neonatal Med 1998;3:43–6. | Design |
| Hee L. Likelihood ratios for the prediction of preterm delivery with biomarkers. Acta Obstet Gynecol Scand 2011;90:1189–99. https://doi.org/10.1111/j.1600-0412.2011.01187.x | Design |
| Herbst A, Nilsson C. Diagnosis of early preterm labour. BJOG 2006;113(Suppl. 3):60–7 | Design |
| Heyborne KD. Fetal fibronectin testing in threatened preterm labor: time for more study! Am J Obstet Gynecol 2017;217:94 | Design |
| Hezelgrave NL, Shennan AH, David AL. Rational testing tests to predict imminent delivery in threatened preterm labour. BMJ 2015;350:2183 | Design |
| Jeavons W. Sterile speculum exams & fFN collection. AWHONN Lifelines 2005;9:236–40 | Design |
| Kiss H, Ahner R, Hohlagschwandtner M, Leitich H, Husslein P. Fetal fibronectin as a predictor of term labor: a literature review. Acta Obstet Gynecol Scand 2000;79:3–7 | Design |
| Krupa FG, Faltin D, Cecatti JG, Surita FG, Souza JP. Predictors of preterm birth. Int J Gynaecol Obstet 2006;94:5–11 | Design |
| Kuin RA, Vis JY, Mol BW. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients. Obstet Gynecol 2010;115:186–7. https://doi.org/10.1097/AOG.0b013e3181c885ed | Design |
| Lamont RF, Dragovic B. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study by Shennan et al.
BJOG 2006;113:850–1 | Design |
| McCubbin K, Moore S, MacDonald R, Vaillancourt C. Medical Transfer of Patients in Preterm Labor: Treatments and Tocolytics. Prehosp Emerg Care 2015;19:103–9. https://doi.org/10.3109/10903127.2014.942475 | Design |
| Mundy L, Merlin T, Parrella A. A rapid foetal fibronectin assay as a predictive test for women suspected of being in pre-term labour (Structured abstract). Health Technol Assess 2004;(4) | Design |
| Musaad SM, Melson LC, Boswell RD. Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis. Pathology 2006;38:473–4 | Design |
| National Institute for Health Research. PartoSure™ Time to Delivery Test in Suspected Premature Labour. National Institute for Health Research; 2013 | Design |
| O’Sullivan M. Fetal fibronectin as a tool to reduce preterm labour admissions. Australian Midwifery News 2006;6:14–5 | Design |
| Owen P. Fetal fibronectin detection for prediction of preterm birth in low risk women. Br J Obstet Gynaecol 1995;102:1019 | Design |
| Plaut M. Fetal fibronectin and the safety of outpatient management of preterm labor symptoms. Am J Obstet Gynecol 1996;174:797–8 | Design |
| Peterson WE, Sprague AE, Reszel J, Walker M, Fell DB, Perkins SL, et al. Women’s perspectives of the fetal fibronectin testing process: a qualitative descriptive study. BMC Pregnancy & Childbirth 2014;14:190 | Design |
| Plaut M. Fetal fibronectin and the safety of outpatient management of preterm labor symptoms. Am J Obstet Gynecol 1996;174:797–8 | Design |
| Pucillo K, Munneke S. Fetal fibronectin as predictor of preterm delivery in women with symptoms of preterm labor: women with negative FFN test results are unlikely to deliver in the following 2 weeks; observation is still warranted, but expensive interventions may be unnecessary. Evidence-Based Practice 2008;11:11–12 | Design |
| Rizzo G, Arduini D. Obstetrical Markes for Very Premature Delivery. In Bevilacqua G, editor. Florence: 8th World Congress of Perinatal Medicine; 2007 | Design |
| Rizzo G, Capponi A, Angelini E, Muscatello A. Ultrasonographic and Biochemical Markers of Preterm Birth. In Carrera JM, Cabero L, Baraibar R, editors. Barcelona: 5th World Congress of Perinatal Medicine; 2007 | Design |
| Ross GN, Ridout AE, Shennan AH. Optimal clinical risk prediction can be achieved by combining quantitative fetal fibronectin and cervical length, and avoiding thresholds. Acta Obstet Gynecol Scand 2016;95:956. https://doi.org/10.1111/aogs.12922 | Design |
| Sanchez-Ramos L. The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes. Obstet Gynecol 2003;102:196 | Design |
| Schindhelm RK, Hoogenberg J, de Vos MT, Tegelaers FP. Analytical performance of quantitative fetal fibronectin assay. Ultrasound Obstet Gynecol 2016;47:127. https://doi.org/10.1002/uog.15824 | Design |
| Siassakos D, O’Brien K, Draycott T. Healthcare evaluation of the use of atosiban and fibronectin for the management of pre-term labour. J Obstet Gynaecol 2009;29:507–11. https://doi.org/10.1080/01443610903003191 | Design |
| Vis JY, Wilms FF, Oudijk MA, Porath MM, Scheepers HC, Bloemenkamp KW, et al. Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial). BMC Pregnancy Childbirth 2009;9:38. https://doi.org/10.1186/1471-2393-9-38 | Design |
| Vivanti AJ, Benachi A, Rouzier R. ‘Individualized assessment of preterm birth risk using two modified prediction models’ from M. Mailath-Pokorny and colleagues. Eur J Obstet Gynecol Reprod Biol 2015;188:136–7. https://doi.org/10.1016/j.ejogrb.2015.03.013 | Design |
| White K. Rapid test for fetal fibronectin measures preterm risk for women. Journal of Womens Health 1998;7:1076 | Design |
| Wiqvist N. Fetal fibronectin and preterm birth. Acta Obstetricia Et Gynecologica Scandinavica 1993;72:507–8 | Design |
| Bastek JA, Sammel MD, Srinivas SK, McShea MA, Foreman MN, Elovitz MA, et al. Clinical prediction rules for preterm birth can risk stratify patients presenting with preterm labor. Am J Obstet Gynecol 2012;1:S219–20 | Design |
| Bastek JA, Sammel MD, Srinivas SK, McShea MA, Foreman MN, Elovitz MA, Metlay JP. Clinical prediction rules for preterm birth in patients presenting with preterm labor. Obstet Gynecol 2012;119:1119–28. https://doi.org/10.1097/AOG.0b013e31825503e5 | Design |
| Tan H, Wen SW, Chen XK, Demissie K, Walker M. Early prediction of preterm birth for singleton, twin, and triplet pregnancies. Eur J Obstet Gynecol Reprod Biol 2007;131:132–7 | Design |
| Abdelazim IA, Al-Sherbeeny MM, Ibrahim MEM, Fahmy AA, Rabei NH, Aziz Khalifa AA. Insulin-like growth factor binding protein-1/alpha-fetoprotein versus placental alpha microglobulin-1 for diagnosis of premature fetal membranes rupture. Acta Medica International 2016;3:69–74 | Design |
| Akhmetgaliev AR, Fatkullin IF, Munavirova AA, Fatkullin FI. Algorithm to identify the signs of threatened preterm labour. Kazanskii Meditsinskii Zhurnal 2017;98:132–6 | Language |
| Benoist G. [Prediction of preterm delivery in symptomatic women (preterm labor).] J Gynecol Obstet Biol Reprod 2016;45:1346–63 | Language |
| Di Renzo GC, Giardina I, Coata G, Di Tommaso M, Facchinetti F, Petraglia F, et al. [Identification of preterm labor: the role of the fibronectin and ultrasound cervicometry and their association.] Minerva Ginecol 2011;63:477–83 | Language |
| Florjański J, Kłósek A, Zalewski J, Tomiałowicz M, Fuchs T, Heimrath J, Pajak J. [Ultrasonographic assessment of cervical length and measurement of fetal fibronectin level in cervical secretion of pregnant women in prophylaxis of premature deliveries.] Ginekol Pol 2001;72:1139–43 | Language |
| Hampl M, Friese K, Hofmann I, Melchert F. [Quantitative determination of fetal fibronectin in cervical smears: a new marker for evaluating the risk of premature labor.] Geburtshilfe Frauenheilkd 1994;54:685–90. https://doi.org/10.1055/s-2007-1023624 | Language |
| Hampl M, Hofmann I, Gallati H, Melchert F, Friese K. Fetal fibronectin, tumor-necrosis-factor and interleukin-6 – new diagnosis of preterm delivery and rupture of the membranes. Arch Gynecol Obstet 1993;254:1470–2 | Language |
| Helmer H, Brunbauer M, Schatten C, Rohrmeister K, Husslein P. Treatment with the oxytocin receptor antagonist atosiban in patients with risk of pre-term delivery. Geburtshilfe Und Frauenheilkunde 2001;61:755–60 | Language |
| Hincz P, Wilczyński J, Pawłowicz P, Borowski D, Krekora M, Szaflik K. [Fetal fibronectin as a predictor of preterm delivery in patients with preterm contractions and cervical changes.] Ginekol Pol 2000;71:728–32 | Language |
| Lorenz-Eberhardt G, Weiss PAM, Haas J, Puerstner P, Adelwoehrer NE. Premature delivery and fetal fibronectin in the cervical and vaginal secretion. Geburtshilfe und Frauenheilkunde 1994;54:414–6 | Language |
| Mansouri A, Tadjerouni A, El Rabiey G, Baube S, Garnier G, Tribalat S. [Is fetal fibronectin a valid test predictive of premature labor?.] Contracept Fertil Sex 1997;25:380–4 | Language |
| Roubille M, Mailliavin A, Biguet-Vernier B, Bon C, Golfier F, Pichot JC. [Fetal fibronectin as predictor of preterm birth.] Ann Biol Clin 1999;57:93–7 | Language |
| Surbek D, Bösiger H, Pavic N, Huber P, Almendral AC, Holzgreve W. [Fetal fibronectin as a marker of prematurity in a high risk patient sample.] Z Geburtshilfe Neonatol 1997;201:15–20 | Language |
| Tchobroutsky C. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. Contraception Fertilite Sexualite 1998;26:23–5 | Language |
| Velasco JG, Gonzalez AG. Febronectin and prevention of preterm delivery. Medicina Clinica 1995;105:54–5 | Language |
| Werlen S, Raia T, Di Bartolomeo A, Chauleur C. [Preterm labor: Reproducibility of detection test of PAMG-1 before and after digital examination, and transvaginal ultrasound cervical length.] Gynecol Obstet Fertil 2015;43:640–5. https://doi.org/10.1016/j.gyobfe.2015.07.002 | Language |
| Wilms FF, van Stralen G, Porath MM, Papatsonis DN, Oei SG, Mol BW, Scherjon S. [Predicating imminent preterm labour based on a determination of foetal fibronectin in a vaginal smear.] Ned Tijdschr Geneeskd 2009;153:B398 | Language |
| Abbott DS, Radford SK, Seed PT, Tribe RM, Shennan AH. Evaluation of a quantitative fetal fibronectin test for spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol 2013;208:122.e1–6. https://doi.org/10.1016/j.ajog.2012.10.890 | Outcome |
| Amabebe E, Reynolds S, Stern V, Stafford G, Paley M, Anumba DO. Cervicovaginal Fluid Acetate: A Metabolite Marker of Preterm Birth in Symptomatic Pregnant Women. Front Med 2016;3:48. https://doi.org/10.3389/fmed.2016.00048 | Outcome |
| Asakura H, Fukami T, Kurashina R, Tateyama N, Doi D, Takeshita T. Significance of cervical gland area in predicting preterm birth for patients with threatened preterm delivery: comparison with cervical length and fetal fibronectin. Gynecol Obstet Invest 2009;68:1–8. https://doi.org/10.1159/000209394 | Outcome |
| Ben-Haroush A, Poran E, Yogev Y, Glezerman M. Vaginal fetal fibronectin evaluation before and immediately after ultrasonographic vaginal cervical length measurements in symptomatic women at risk of preterm birth: a pilot study. J Matern Fetal Neonatal Med 2010;23:854–6. https://doi.org/10.3109/14767050903300977 | Outcome |
| Blackwell S, Shen X, Petrilla AA, Sullivan E, Troeger K. 404: Utilization of fetal fibronectin testing and timing of delivery among emergency department admissions with symptoms of preterm labor. Am J Obstet Gynecol 2017;216:S241-S | Outcome |
| Bogavac M, Simin N, Ranisavljević M, Budisić L. The role of insulin-like growth factor in prediction and prevention of preterm delivery. Vojnosanit Pregl 2010;67:883–6 | Outcome |
| Bolt LA, Chandiramani M, De Greeff A, Seed P, Shennan AH. Does fetal fibronectin testing change patient management in women at risk of preterm labour? Eur J Obstet Gynecol Reprod Biol 2009;146:180–3 | Outcome |
| Bredaki FE, Lawin-O’Brien A, Jesner O, Forya F, Biswas C, David AL. Quantitative fetal fibronectin to triage women with threatened preterm labour in clinical practice. BJOG 2015;122:104 | Outcome |
| Browne H, Jassel I, Dhanji A, Bonney E, Simpson N. Use of quantitative fetal fibronectin may improve risk assessment in symptomatic women at risk of preterm birth. Arch Dis Child Fetal Neonatal Ed Conference: 16th Annual Conference of the British Maternal and Fetal Medicine Society Dublin Ireland Conference Publication 2013;98(no pagination) | Outcome |
| Chandiramani M, De Greeff A, Filmer J, Bolt LA, Smout E, Shennan AH. The affirm study: Assessment of fetal fibronectin testing to improve preterm management. Arch Dis Child Fetal Neonatal Ed 2011;96:Fa65–6 | Outcome |
| Echebiri NC, McDoom MM, Aalto M, Pullen J, Doyle NM. Placental alpha-microglobulin-1 and combined traditional diagnostic test: a cost–benefit analysis. Obstetrics & Gynecology 2014;123:3S-S | Outcome |
| Elizur SE, Yinon Y, Epstein GS, Seidman DS, Schiff E, Sivan E. Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside test. Am J Perinatol 2005;22:305–9. https://doi.org/10.1055/s-2005-870895 | Outcome |
| Fiorini F, Isted A, Hezelgrave NL, Shennan AH. Prediction of spontaneous preterm birth with quantitative fetal fibronectin in patients with bulging fetal membranes. BJOG 2015;122:123 | Outcome |
| Fiorini F, Isted A, Hezelgrave NL, Shennan AH. Quantitative fetal fibronectin predicts preterm birth in women with bulging fetal membranes. Eur J Obstet Gynecol Reprod Biol 2016;203:127–31. https://doi.org/10.1016/j.ejogrb.2016.05.046 | Outcome |
| Gardner M, Rouse D, Joffe G. Cost–benefit analysis of fetal fibronectin screening. Am J Obstet Gynecol 1998;178:S121 | Outcome |
| Giles W, Knox M, Madsen G, Bisits A, Smith R. The effect of fetal fibronectin usage on admissions to a tertiary maternal fetal medicine unit and cost savings. Am J Obstet Gynecol 1998;178:S121 | Outcome |
| Goepfert AR, Goldenberg RL, Andrews WW, Hauth JC, Mercer B, Iams J, et al. The Preterm Prediction Study: Association between cervical interleukin 6 concentration and spontaneous preterm birth. Am J Obstet Gynecol 2001;184:483–8 | Outcome |
| Gomez R, Romero R, Montiel C, Magendzo A, Pino P, Nien J, et al. Cervico-vaginal fetal fibronectin improves the prediction of preterm delivery estimated by sonographic cervical length in patients with preterm labor and intact membranes. Am J Obstet Gynecol 2002;187(Suppl. 6):S80 | Outcome |
| Hadzi Lega M, Daneva Markova A, Girevski V. Correlation of cervical length and different biochemical markers in spontaneus preterm birth up to 7 days in symptomatic patients. J Perinat Med Conference: 12th World Congress of Perinatal Medicine 2015;43(no pagination) | Outcome |
| Hadzi Lega M, Daneva Markova A, Stefanovic M, Tanturovski M. Interleukin 6 and fetal fibronectin as a predictors of preterm delivery in symptomatic patients. Bosnian journal of basic medical sciences/Udruzenje basicnih mediciniskih znanosti = Association of Basic Medical Sciences 2015;15:51–6 | Outcome |
| Hadzi Lega M, Daneva Markova A, Tanturovski M. Interleukin 6 and fetal fibronectin in prediction of preterm delivery in symptomatic patients. J Matern Fetal Neonatal Med 2014;27:373 | Outcome |
| Hadži-Lega M, Markova AD, Stefanovic M, Tanturovski M. Combination of selected biochemical markers and cervical length in the prediction of impending preterm delivery in symptomatic patients. Clin Exp Obstet Gynecol 2016;43:154–60 | Outcome |
| Hadži-Lega M, Markova AD, Stefanovic M, Tanturovski M. Correlation of cervical length, fetal fibronectin, phIGFBP-1, and cytokines in spontaneous preterm birth up to 14 days from sampling. J Perinat Med 2015;43:545–51. https://doi.org/10.1515/jpm-2014-0275 | Outcome |
| Kekki M, Kurki T, Kärkkäinen T, Hiilesmaa V, Paavonen J, Rutanen EM. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2001;80:546–51 | Outcome |
| Latifagic A, Balic D, Fatusic Z, Hudic I, Kapidzic M, Habibovic A. Insulin-like growth factor-binding protein-1 (IGFBP-1) in cervical secretions in women with symptoms of preterm delivery. Medicinski Glasnik 2008;5:121–4 | Outcome |
| Paternoster D, Riboni F, Vitulo A, Plebani M, Dell’Avanzo M, Battagliarin G, et al. Phosphorylated insulin-like growth factor binding protein-1 in cervical secretions and sonographic cervical length in the prediction of spontaneous preterm delivery. Ultrasound Obstet Gynecol 2009;34:437–40. https://doi.org/10.1002/uog.6428 | Outcome |
| Paternoster DM, Cardascia L, Narne S, Parise A, De Paoli M, Plebani M, et al.
Predictive Markers of Preterm Labour. In Cosmi EV, editor. Alghero: 2nd International Congress New Technologies in Reproductive Medicine, Neonatology and Gynecology; 1999 | Outcome |
| Paternoster DM, Muresan D, Vitulo A, Serena A, Battagliarin G, Dell’avanzo M, Nicolini U. Cervical phIGFBP-1 in the evaluation of the risk of preterm delivery. Acta Obstet Gynecol Scand 2007;86:151–5 | Outcome |
| Rahkonen L, Unkila-Kallio L, Nuutila M, Sainio S, Saisto T, Rutanen EM, Paavonen J. Cervical length measurement and cervical phosphorylated insulin-like growth factor binding protein-1 testing in prediction of preterm birth in patients reporting uterine contractions. Acta Obstet Gynecol Scand 2009;88:901–8. https://doi.org/10.1080/00016340903104281 | Outcome |
| Vĕtr M, Kudela M, Prásilová J. Fetal fibronectin in patients at increased risk for premature birth. Acta Univ Palacki Olomuc Fac Med 1996;140:55–7 | Outcome |
| Centra M, Coata G, Picchiassi E, Alfonsi L, Meniconi S, Bini V, et al. Evaluation of quantitative fFn test in predicting the risk of preterm birth. J Perinat Med 2017;45:91–8. https://doi.org/10.1515/jpm-2015-0414 | Outcome |
| Anonymous. fFN testing not always so accurate. Contemporary OB/GYN 2009;54:18 | Population |
| Abbott D, Chandiramani M, Seed P, Tribe R, Shennan A. Quantification of fetal fibronectin improves the accuracy of prediction of spontaneous preterm birth in high risk asymptomatic women. Reprod Sci 2013;20:124A-A | Population |
| Abbott D, Hezelgrave N, Seed P, Bennett P, Chandiramani M, David A, et al. EQUIPP: Evaluation of fetal fibronectin with a novel bedside quantitative instrument for the prediction of preterm birth. J Matern Fetal Neonatal Med 2014;27:368–9 | Population |
| Abbott D, Smout E, Foster C, Van der Westhuizen M, Seed P, Shennan AH. The development and validation of a prediction tool for spontaneous preterm birth incorporating fetal fibronectin and cervical length. BJOG 2012;119:e1-e | Population |
| Audibert F, Fortin S, Delvin E, Djemli A, Brunet S, Dubé J, Fraser WD. Contingent use of fetal fibronectin testing and cervical length measurement in women with preterm labour. J Obstet Gynaecol Can 2010;32:307–12 | Population |
| Calvert B, Hezelgrave N, Seed P, Shennan A. Quantitative fetal fibronectin and birth outcome in women with previous cervical surgery and a short cervix. BJOG 2015;122:102–3 | Population |
| Esplin M. 6: The use of serial cervical length and quantitative fetal fibronectin to identify nulliparous women at risk of subsequent spontaneous preterm birth. Am J Obstet Gynecol 2016;214:S4–5 | Population |
| Esplin MS, Elovitz MA, Iams JD, Parker CB, Wapner RJ, Grobman WA, et al. Predictive accuracy of serial transvaginal cervical lengths and quantitative vaginal fetal fibronectin levels for spontaneous preterm birth among nulliparous women. JAMA 2017;317:1047–56. https://doi.org/10.1001/jama.2017.1373 | Population |
| Goldenberg R, Iams J, Mercer M, Meis P, Mowad A, Copper R, et al. Fetal fibronectin and spontaneous preterm birth. Am J Obstet Gynecol 1995;172:254 | Population |
| Goldenberg RI. The preterm prediction study: Patterns of cervicovaginal fetal fibronectin (FFN) as predictors of subsequent FFN and spontaneous preterm delivery (SPD). Am J Obstet Gynecol 1997;176:S53 | Population |
| Goldenberg RL. The preterm prediction study: Sequential cervical length and fetal fibronectin testing for the prediction of spontaneous preterm birth (SPB). Am J Obstet Gynecol 1999;180:S27 | Population |
| Hughes K, Sim S, Roman A, Michalak K, Kane S, Sheehan P. Outcomes and predictive tests from a dedicated specialist clinic for women at high risk of preterm labour: A ten year audit. Aust N Z J Obstet Gynaecol 2017;57:405–11. https://doi.org/10.1111/ajo.12610 | Population |
| Jeurgens-Borst AJ, Bekkers RL, Sporken JM, van den Berg PP. Use of insulin like growth factor binding protein-1 in the diagnosis of ruptured fetal membranes. Eur J Obstet Gynecol Reprod Biol 2002;102:11–14 | Population |
| Kalafat E, Yuce T, Tanju O, Koc A. Preterm premature rupture of membrane assessment via transperineal ultrasonography: a diagnostic accuracy study. J Matern Fetal Neonatal Med 2016;29:3690–4. https://doi.org/10.3109/14767058.2016.1140742 | Population |
| Kwek K, Khi C, Ting HS, Yeo GS. Evaluation of a bedside test for phosphorylated insulin-like growth factor binding protein-1 in preterm labour. Ann Acad Med Singap 2004;33:780–3 | Population |
| Mešić Ðogić L, Mićić D, Omeragić F, Kovač R, Fazlagić S. IGFBP-1 marker of cervical ripening and predictor of preterm birth. Med Glas 2016;13:118–24. https://doi.org/10.17392/856-16 | Population |
| Paternoster D, Pignatara R, Grella P. Insulin-like Growth Factor Protein Test (IGFBP-1) in Predicting Preterm Delivery. Cosmi EV, editor. Rome: 2nd World Congress on Labour and Delivery; May 1997 | Population |
| Paternoster DM, Pignataro R, Stella A, Bertoldini M, Bracciante M. New Biotechnologies in the Prediction of Preterm Birth. Cosmi EV, editor. Fiuggi: 16th International Congress on the Fetus as a Patient; 2000 | Population |
| Sheehan A, Brennecke S, Boland R, Smith J. The use of fetal fibronectin testing in clinical practice: an audit of referrals for threatened preterm labour to the Victorian perinatal emergency retrieval service from non-tertiary hospitals. J Pediatr Child Health 2017;53:90 | Test |
| Abbott D, Radford S, Seed P, Shennan AH. The first report of a quantitative fetal fibronectin bedside analyser in the prediction of preterm birth in symptomatic women. BJOG 2012;119:e1–2 | Test |
| Abenhaim HA, Morin L, Benjamin A. Does availability of fetal firbonectin testing in the management of threatened preterm labour affect the utilization of hospital resources? Obstet Gynaecol Can 2005;27:689–94 | Test |
| Ai F, Li GQ, Jiang J, Dong XD. Neutrophil elastase and fetal fibronectin levels as predictors of single-birth prematurity. Exp Ther Med 2015;10:665–70. https://doi.org/10.3892/etm.2015.2508 | Test |
| Akers A, Jarzembowski JA, Johnson CT, Lieberman RW, Dalton VK. Examining the relationship between positive mid-gestational fetal fibronectin assays and histological evidence of acute placental inflammation. J Perinat Med 2007;35:36–42. https://doi.org/10.1515/JPM.2007.005 | Test |
| Allen KA, Kiwi R. Clinical utilization of a rapid fetal fibronectin assay. Ann Clin Lab Sci 2000;30:323–4 | Test |
| Andersen HF. Use of fetal fibronectin in women at risk for preterm delivery. Clin Obstet Gynecol 2000;43:746–58 | Test |
| Anwar A, Lindow SW, Greaves L, Hall S, Jha R. The use of fetal fibronectin in suspected pre-term labour. J Obstet Gynaecol 2014;34:45–7. https://doi.org/10.3109/01443615.2013.823923 | Test |
| Armson A, Dodds L, Dooley K, Howlett A, McPhee A, Scott H. Fetal fibronectin testing for suspected preterm labour in Nova Scotia. Am J Obstet Gynecol 2004;191:S115-S | Test |
| Ayala-Mendez JA, Kurtzman J, Rosales-Ortiz S, Martinez-Alvarez O, Das A, Jimenez-Solis G. Fetal fibronectin status markedly modifies the risk of preterm delivery in low risk patients with symptomatic preterm labor and cervical shortening. Am J Obstet Gynecol 2008;199:S235-S | Test |
| Bare T, Manoku N. Fetal fibronectin and cericometry in patients at increased risk for premature birth. Acta Microbiologica Hellenica 2015;60:186 | Test |
| Bartnicki J, Casal D, Kreaden US, Saling E, Vetter K. Fetal fibronectin in vaginal specimens predicts preterm delivery and very-low-birth-weight infants. Am J Obstet Gynecol 1996;174:971–4 | Test |
| Bayar E, Wietek N, Page L, Girling J. A service evaluation of quantitative fetal fibronectin (qfFN) in symptomatic women as a predictor of preterm birth at West Middlesex University Hospital (WMUH): potential to reduce bed occupancy further. BJOG 2015;122:97 | Test |
| Benson JE, Landy HJ, Ghidini A, Drassinower D, Poggi SH. Fetal fibronectin for evaluation of preterm labor in the setting of cervical cerclage. J Matern Fetal Neonatal Med 2012;25:2330–2. https://doi.org/10.3109/14767058.2012.695820 | Test |
| Berghella V, Hayes E, Visintine J, Baxter JK. Fetal fibronectin testing for reducing the risk of preterm birth. Cochrane Database Syst Rev 2008;4:CD006843. https://doi.org/10.1002/14651858.CD006843.pub2 | Test |
| Berghella V, Saccone G. Fetal fibronectin testing for prevention of preterm birth in singleton pregnancies with threatened preterm labor: a systematic review and metaanalysis of randomized controlled trials. Am J Obstet Gynecol 2016;215:431–8. https://doi.org/10.1016/j.ajog.2016.04.038 | Test |
| Bolt L, Chandiramani M, De Greeff A, Shennan A. Does fetal fibronectin testing change patient management in women at risk of pre-term labour? Int J Gynecol Obstet 2009;107:S527–8 | Test |
| Boots AB, Sanchez-Ramos L, Bowers DM, Kaunitz AM, Zamora J, Schlattmann P. The short-term prediction of preterm birth: a systematic review and diagnostic metaanalysis. Am J Obstet Gynecol 2014;210:54.e1–54.e10. https://doi.org/10.1016/j.ajog.2013.09.004 | Test |
| Bruijn M, Vis J, Wilms F, Oudijk M, Kwee A, Porath M, et al. The contribution of vaginal examination to risk stratification of women with signs of preterm labor before 34 weeks gestation: the APOSTEL1-cohort. Am J Obstet Gynecol 2014;210(Suppl. 1):S362–3 | Test |
| Burrus D, Adair D, Aptel K, Ernest J, Frye A, Veille J. The effect of digital cervical exam on measured levels of fetal fibronectin. Am J Obstet Gynecol 1996;174:352 | Test |
| Burrus DR, Ernest JM, Veille JC. Fetal fibronectin, interleukin-6, and C-reactive protein are useful in establishing prognostic subcategories of idiopathic preterm labor. Am J Obstet Gynecol 1995;173:1258–62 | Test |
| Burwick RM, Zork NM, Lee GT, Ross MG, Kjos SL. Cervilenz assessment of cervical length compared to fetal fibronectin in the prediction of preterm delivery in women with threatened preterm labor. J Matern Fetal Neonatal Med 2011;24:127–31. https://doi.org/10.3109/14767058.2010.529201 | Test |
| Chandiramani M, Das A, Bolt LA, de Greeff A, Filmer J, Shennan A. Assessment of fetal fibronectin testing to improve preterm birth management. Reprod Sci 2014;21:151A–2A | Test |
| Cheung KW, Ngu SF, Lee CP. Fetal fibronectin test on Chinese women with symptoms of preterm labour: a pilot study. Hong Kong Med J 2013;19:424–8. https://doi.org/10.12809/hkmj133861 | Test |
| Chien PF, Khan KS, Ogston S, Owen P. The diagnostic accuracy of cervico-vaginal fetal fibronectin in predicting preterm delivery: an overview (Structured abstract). Br J Obstet Gynaecol 1997;104:436–44. URL: http://onlinelibrary.wiley.com/o/cochrane/cldare/articles/DARE-11997000650/frame.html (accessed September 2017) | Test |
| Clock C, Kurtzman J. Positive fetal fibronectin status is associated with dynamic cervical shortening in patients with normal baseline cervical length and symptomatic contractions. Am J Obstet Gynecol 2007;197:S199-S | Test |
| Coleman MAG, Keelan JA, McCowan LME, Townend KM, Mitchell MD. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1 beta, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol 2001;95:154–8 | Test |
| Cox S, Little B, Dax J, Leveno K. Fetal fibronectin and preterm delivery. Am J Obstet Gynecol 1996;174:306 | Test |
| DeFranco EA, Lewis DF, Odibo AO. Improving the screening accuracy for preterm labor: is the combination of fetal fibronectin and cervical length in symptomatic patients a useful predictor of preterm birth? A systematic review. Am J Obstet Gynecol 2013;208:233.e1–6. https://doi.org/10.1016/j.ajog.2012.12.015 | Test |
| Deshpande SN, van Asselt AD, Tomini F, Armstrong N, Allen A, Noake C, et al. Rapid fetal fibronectin testing to predict preterm birth in women with symptoms of premature labour: a systematic review and cost analysis. Health Technol Assess 2013;17(40). https://doi.org/10.3310/hta17400 | Test |
| Díaz J, Chedraui P, Hidalgo L, Medina M. The clinical utility of fetal fibronectin in the prediction of pre-term birth in a low socio-economic setting hospital in Ecuador. J Matern Fetal Neonatal Med 2009;22:89–93. https://doi.org/10.1080/14767050802464551 | Test |
| Dutta D, Norman JE. Pilot study into the efficacy of foetal fibronectin testing in minimising hospital admissions in women presenting with symptoms of preterm labour: a randomised controlled trial of obstetric and neonatal outcomes. Arch Gynecol Obstet 2011;284:559–65. https://doi.org/10.1007/s00404-010-1712-x | Test |
| Ehsanipoor RM, Swank ML, Jwa SC, Wing DA, Tarabulsi G, Blakemore KJ. Placental α-microglobulin-1 in vaginal secretions of women with evidence of preterm labor. Am J Perinatol 2016;33:208–13. https://doi.org/10.1055/s-0035-1563710 | Test |
| Elliot J, Maharajan P, Thampi P. Test that predicts premature labour: efficacy of foetal fibronectin test and its cost implications. Arch Dis Child Fetal Neonatal Ed 2012;97:A19–20 | Test |
| Farag AH, Mohammed MM, Ellaithy MI, Salama HA. Blind vaginal fetal fibronectin swab for prediction of preterm birth. J Obstet Gynaecol Res 2015;41:1009–17. https://doi.org/10.1111/jog.12666 | Test |
| Fell DB, Sprague AE, Grimshaw JM, Yasseen AS, Coyle D, Dunn SI, et al. Evaluation of the impact of fetal fibronectin test implementation on hospital admissions for preterm labour in Ontario: a multiple baseline time-series design. BJOG 2014;121:438–46. https://doi.org/10.1111/1471-0528.12511 | Test |
| Foong E, Chye Chuah S. Clinical application of quantitative fetal fibronectin testing in the management of preterm labour at a regional hospital. Aust N Z J Obstet Gynaecol 2016;56:37–8 | Test |
| Foxman EF, Jarolim P. Use of the fetal fibronectin test in decisions to admit to hospital for preterm labor. Clin Chem 2004;50:663–5. https://doi.org/10.1373/clinchem.2003.028720 | Test |
| Franco R, Shaw K, Williams C, Hickok D. Risk of preterm delivery with a positive fetal fibronectin test result and a normal cervical length. Obstet Gynecol 2005;105:114S-S | Test |
| Fricke E. A quality analysis of the evaluation of preterm labor. Am J Obstet Gynecol 2015;1:S66 | Test |
| Gaikwad VA, Rajput UG, Puri MS. Cervico vaginal fluid fibronectin level in assessing risk of preterm labour. Res J Pharm Biol Chem Sci 2014;5:156–62 | Test |
| Gao L, Zhang JP, Chen H, Guo ZJ, Chen LB, Tan JP, et al. Fetal fibronectin detection for preterm birth prediction. Genet Mol Res 2014;13:1323–8. https://doi.org/10.4238/2014.February.28.4 | Test |
| Garite T, Lucah AC, Williams C, Bobritchi B, Lapointe J. A comparison of speculum and non-speculum collection of cervicovaginal SWAB specimens for fetal fibronectin testing. Am J Obstet Gynecol 2005;193:S52-S | Test |
| Giles W, Bisits A, Knox M, Madsen G, Smith R. The effect of fetal fibronectin testing on admissions to a tertiary maternal-fetal medicine unit and cost savings. Am J Obstet Gynecol 2000;182:439–42 | Test |
| Goepfert AR, Andrews WW. The preterm prediction study: association between cervical interleukin-6 (IL-6), fetal fibronectin (FFN), and spontaneous preterm birth (SPTB). Am J Obstet Gynecol 1997;176:S6 | Test |
| Rossel Goffeng A, Holst E, Milsom I, Lindstedt G, Lundberg PA, Andersch B. Factors influencing vaginal fetal fibronectin concentrations during pregnancy. Gynecol Obstet Invest 1999;47:83–8 | Test |
| Goffinet F, Kayem G, Maillard F, Trébéden H, Cabrol D, Weill B, Batteux F. Detection of interleukin 6 mRNA by RT-PCR in vaginal secretions: association with preterm delivery and neonatal infection in women with preterm labour and intact membranes. Eur J Obstet Gynecol Reprod Biol 2005;123:167–73 | Test |
| Golic M, Siedentopf JP, Pauly F, Hinkson L, Henrich W, Tucher E. Influence of transvaginal ultrasound examination on quantitative vaginal fibronectin measurements: a prospective evaluation study. J Perinat Med 2017;45:85–9. https://doi.org/10.1515/jpm-2015-0270 | Test |
| Grobman WA, Welshman EE, Calhoun EA. Does fetal fibronectin use in the diagnosis of preterm labor affect physician behavior and health care costs? A randomized trial. Am J Obstet Gynecol 2004;191:235–40. https://doi.org/10.1016/j.ajog.2003.11.034 | Test |
| Groom KM, Liu E, Allenby K. The impact of fetal fibronectin testing for women with symptoms of preterm labour in routine clinical practice within a New Zealand population. Aust N Z J Obstet Gynaecol 2006;46:440–5 | Test |
| Harstall C. Using fetal fibronectin to diagnose pre-term labour: the role of rapid fetal fibronectin assay in the management of spontaneous preterm labour (Structured abstract). Health Technol Assess 2008(4). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32008100049/frame.html (accessed September 2017) | Test |
| Helmer H, Brunbauer M, Rohrmeister K. Exploring the role of Tractocile in everyday clinical practice. BJOG 2003;110(Suppl. 20):113–15 | Test |
| Heng YJ, Pennell CE, Chua HN, Perkins JE, Lye SJ. Whole blood gene expression profile associated with spontaneous preterm birth in women with threatened preterm labor. PLOS ONE 2014;9:e96901. https://doi.org/10.1371/journal.pone.0096901 | Test |
| Hermans FJR, Bruijn MMC, Vis JY, Wilms FF, Oudijk MA, Porath MM, et al. Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days. Acta Obstetricia Et Gynecologica Scandinavica 2015;94:715–21 | Test |
| Hincz P, Wilczynski J, Kozarzewski M, Borowski D, Krekora M, Szaflik K. Two-step test: Fetal fibronectin and sonographic examination of the uterine cervix in patients presenting with preterm contractions. Am J Obstet Gynecol 2000;182:S44 | Test |
| Hincz P, Wilczynski J, Kozarzewski M, Szaflik K. Two-step test: the combined use of fetal fibronectin and sonographic examination of the uterine cervix for prediction of preterm delivery in symptomatic patients. Acta Obstet Gynecol Scand 2002;81:58–63 | Test |
| Honest H, Forbes CA, Durée KH, Norman G, Duffy SB, Tsourapas A, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009;13(43). https://doi.org/10.3310/hta13430 | Test |
| Iams JD, Casal D, McGregor JA, Goodwin TM, Kreaden US, Lowensohn R, Lockitch G. Fetal fibronectin improves the accuracy of diagnosis of preterm labor. Am J Obstet Gynecol 1995;173:141–5 | Test |
| Ibrahim MI, Sherif A, El-Kady M, Ellaithy M, Husseiny A, Kamal M, El-Din NN. Can three-dimensional ultrasound measurement of fetal adrenal gland enlargement predict preterm birth? Arch Gynecol Obstet 2015;292:569–78. https://doi.org/10.1007/s00404-015-3668-3 | Test |
| Incerti M, Ghidini A, Korker V, Pezzullo JC. Performance of cervicovaginal fetal fibronectin in a community hospital setting. Arch Gynecol Obstet 2007;275:347–51. https://doi.org/10.1007/s00404-006-0267-3 | Test |
| Joffe G, Jacques D, Burton B, Bemis-Heys R, Shelburne P, Lovelace. Impact of fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol. 1998;178(1 PART 2):S11 | Test |
| Joffe GM, Jacques D, Bemis-Heys R, Burton R, Skram B, Shelburne P. Impact of the fetal fibronectin assay on admissions for preterm labor. Am J Obstet Gynecol 1999;180:581–6 | Test |
| Karamisheva V, Ivanov S, Nachev A. Comparison of two rapid strip tests based on ffn and pamg-1 for the prediction of imminent spontaneous preterm delivery. Comptes Rendus De L Academie Bulgare Des Sciences 2016;69:661–6 | Test |
| Keeler S, Roman A, Coletta J, Kiefer D, Rust O. Fetal fibronectin testing prior to ultrasound-indicated CERC1 age: can it predict procedure success? Am J Obstet Gynecol 2007;197:S199-S | Test |
| Keeler SM, Roman AS, Coletta JM, Kiefer DG, Feuerman M, Rust OA, et al. Fetal fibronectin testing in patients with short cervix in the midtrimester: can it identify optimal candidates for ultrasound-indicated cerclage? Am J Obstet Gynecol 2009;200:158.e1–6 | Test |
| Langer B, Boudier E, Schlaeder G. Cervico-vaginal fetal fibronectin: predictive value during false labor. Acta Obstet Gynecol Scand 1997;76:218–21 | Test |
| Lee G, Burwick R, Zork N, Kjos S. Does the use of fetal fibronectin in an algorithm for preterm labor reduce triage evaluation times? J Matern Fetal Neonatal Med: the Official Journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2013;26:706–9. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/772/CN-00966772/frame.html (accessed September 2017) | Test |
| Lee SM, Romero R, Park JW, Kim SM, Park CW, Korzeniewski SJ, et al. The clinical significance of a positive Amnisure test in women with preterm labor and intact membranes. J Matern Fetal Neonatal Med 2012;25:1690–8. https://doi.org/10.3109/14767058.2012.657279 | Test |
| Leitich H, Egarter C, Kaider A, Hohlagschwandtner M, Berghammer P, Husslein P. Cervicovaginal fetal fibronectin as a marker for preterm delivery: a meta-analysis. Am J Obstet Gynecol 1999;180:1169–76 | Test |
| Lopez RL, Francis JA, Garite TJ, Dubyak JM. Fetal fibronectin detection as a predictor of preterm birth in actual clinical practice. Am J Obstet Gynecol 2000;182:1103–6 | Test |
| Lowe MP, Zimmerman B, Hansen W. Prospective randomized controlled trial of fetal fibronectin on preterm labor management in a tertiary care center. Am J Obstet Gynecol 2004;190:358–62. https://doi.org/10.1016/j.ajog.2003.08.041 | Test |
| Lu GC, Goldenberg RL, Cliver SP, Kreaden US, Andrews WW. Vaginal fetal fibronectin levels and spontaneous preterm birth in symptomatic women. Obstet Gynecol 2001;97:225–8 | Test |
| MacDonald WA, Bender M, Saxton A. Use of fetal fibronectin in the management of preterm labour in Nunavut. Alaska Med 2007;49(Suppl. 2):215–17 | Test |
| Malak TM, Sizmur F, Bell SC, Taylor DJ. Fetal fibronectin in cervicovaginal secretions as a predictor of preterm birth. Br J Obstet Gynaecol 1996;103:648–53 | Test |
| Marvin KW, Keelan JA, Coleman MA, McCowan LM, Zhou RL, Mitchell MD. Intercellular adhesion molecule-1 (ICAM-1) in cervicovaginal fluid of women presenting with preterm labor: predictive value for preterm delivery. Am J Reprod Immunol 2000;43:264–71 | Test |
| Mateus J, Pereira L, Baxter J, Berghella V, Tolosa J. Effectiveness of fetal fibronectin testing compared with digital cervical assessment of women with preterm contractions. Am J Perinatol 2007;24:381–5. https://doi.org/10.1055/s-2007-981849 | Test |
| Morrison JC, Allbert JR, McLaughlin BN, Whitworth NS, Roberts WE, Martin RW. Oncofetal fibronectin in patients with false labor as a predictor of preterm delivery. Am J Obstet Gynecol 1993;168:538–42 | Test |
| Most O, Langer O, Kerner R, David GB, Calderon I. Can myometrial electrical activity identify patients in preterm labor? Am J Obstet Gynecol 2008;199:378.e1–6. https://doi.org/10.1016/j.ajog.2008.08.003 | Test |
| Musaad SM, Melson CL, Boswell DR. Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand. Pathology 2005;37:226–30 | Test |
| Ness A, Visintine J, Ricci E, Berghella V. Does knowledge of cervical length and fetal fibronectin affect management of women with threatened preterm labor? A randomized trial. Am J Obstet Gynecol 2007;197:426.e1–7 | Test |
| Ness A, Visintine J, Ricci E, Boyle K, Berghella V. Use of fetal fibronectin and transvaginal ultrasound cervical length to triage women with suspected preterm labor: a randomized trial. Am J Obstet Gynecol 2006;195(Suppl. 1):S67. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/777/CN-00582777/frame.html (accessed September 2017) | Test |
| Nguyen T. The cost-effectiveness of fetal fibronectin testing in suspected preterm labor: a randomized trial. Obstet Gynecol 2002;99(Suppl. 4):97s. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/633/CN-00387633/frame.html (accessed September 2017) | Test |
| Owen P, Scott A. Can fetal fibronectin testing improve the management of preterm labour? Clin Exp Obstet Gynecol 1997;24:19–22 | Test |
| Parisaei M, Currie J, O’Gorman N, Morris S, David AL. Implementation of foetal fibronectin testing: admissions, maternal interventions and costs at 1 year. J Obstet Gynaecol 2016;36:888–92 | Test |
| Parker J, Bell R, Brennecke S. Fetal fibronectin in the cervicovaginal fluid of women with threatened preterm labour as a predictor of delivery before 34 weeks’ gestation. Aust N Z J Obstet Gynaecol 1995;35:257–61 | Test |
| Parry E, Singh TG, Dow D, Noovao F. Improved management in threatened preterm labour with rapid fetal fibronectin testing. Aust N Z J Obstet Gynaecol 2006;46:240–1 | Test |
| Plaut MM, Smith W, Kennedy K. Fetal fibronectin: the impact of a rapid test on the treatment of women with preterm labor symptoms. Am J Obstet Gynecol 2003;188:1588–93 | Test |
| Revah A, Hannah ME, Sue-A-Quan AK. Fetal fibronectin as a predictor of preterm birth: an overview. Am J Perinatol 1998;15:613–21. https://doi.org/10.1055/s-2007-994079 | Test |
| Rinehart BK, Terrone DA, Isler CM, Barrilleaux PS, Bufkin L, Morrison JC. Pregnancy outcome in women with preterm labor symptoms without cervical change. Am J Obstet Gynecol 2001;184:1004–7 | Test |
| Rizzo G, Capponi A, Arduini D, Lorido C, Romanini C. The value of fetal fibronectin in cervical and vaginal secretions and of ultrasonographic examination of the uterine cervix in predicting premature delivery for patients with preterm labor and intact membranes. Am J Obstet Gynecol 1996;175:1146–51 | Test |
| Roman AS, Koklanaris N, Paidas MJ, Mulholland J, Levitz M, Rebarber A. ‘Blind’ vaginal fetal fibronectin as a predictor of spontaneous preterm delivery. Obstet Gynecol 2005;105:285–9 | Test |
| Roos C, Schuit E, Scheepers HC, Bloemenkamp KW, Bolte AC, Duvekot HJ, et al. Predictive factors for delivery within 7 days after successful 48-hour treatment of threatened preterm labor. AJP Rep 2015;5:e141–9. https://doi.org/10.1055/s-0035-1552930 | Test |
| Roos C, Vis JY, Scheepers HC, Bloemenkamp KW, Duvekot HJ, van Eyck J, et al. Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis. J Matern Fetal Neonatal Med 2016;29:1556–61. https://doi.org/10.3109/14767058.2015.1053863 | Test |
| Rose CH, McWeeney DT, Brost BC, Davies NP, Watson WJ. Cost-effective standardization of preterm labor evaluation. Am J Obstet Gynecol 2010;203:250.e1–5. https://doi.org/10.1016/j.ajog.2010.06.037 | Test |
| Rossel Goffeng A, Holst E, Milsom I, Lindstedt G, Lundberg PA, Andersch B. Factors influencing vaginal fetal fibronectin concentrations during pregnancy. Gynecol Obstet Invest 1999;47:83–8 | Test |
| Rozenberg P, Goffinet F, Malagrida L, Giudicelli Y, Perdu M, Houssin I, et al. Evaluating the risk of preterm delivery: a comparison of fetal fibronectin and transvaginal ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1997;176:196–9 | Test |
| Sakai M, Sasaki Y, Yamagishi N, Tanebe K, Yoneda S, Saito S. The preterm labor index and fetal fibronectin for prediction of preterm delivery with intact membranes. Obstet Gynecol 2003;101:123–8 | Test |
| Salcedo A, Kurtzman J. Digital cervical exam characteristics stratify the risk of preterm birth based on fetal fibronectin status. Am J Obstet Gynecol 2013;208:S203-S | Test |
| Senden IP, Owen P. Comparison of cervical assessment, fetal fibronectin and fetal breathing in the diagnosis of preterm labour. Clin Exp Obstet Gynecol 1996;23:5–9 | Test |
| Skoll A, St Louis P, Amiri N, Delisle MF, Lalji S. The evaluation of the fetal fibronectin test for prediction of preterm delivery in symptomatic patients. J Obstet Gynaecol Can 2006;28:206–13 | Test |
| Stevens AO, Chauhan SP, Magann EF, Martin RW, Bofill JA, Cushman JL, Morrison JC. Fetal fibronectin and bacterial vaginosis are associated with preterm birth in women who are symptomatic for preterm labor. Am J Obstet Gynecol 2004;190:1582–7. https://doi.org/10.1016/j.ajog.2004.03.059 | Test |
| Stuart RW, Jones RO, Underwood F, Kryka R, Bodor GS. The utility of fetal fibronectin in preterm labor decision making. Am J Clin Path 2007;128:513–4 | Test |
| Sukchaya K, Phupong V. A comparative study of positive rate of placental α-microglobulin-1 test in pre-term pregnant women with and without uterine contraction. J Obstet Gynaecol 2013;33:566–8. https://doi.org/10.3109/01443615.2013.807786 | Test |
| Sullivan A, Hueppchen NA, Satin AJ. Cost effectiveness of bedside fetal fibronectin testing varies according to treatment algorithm. J Matern Fetal Med 2001;10:380–4 | Test |
| Sunagawa S, Takagi K, Ono K, Miyachi K, Kikuchi A. Comparison of biochemical markers and cervical length for predicting preterm delivery. J Obstet Gynaecol Res 2008;34:812–19. https://doi.org/10.1111/j.1447-0756.2008.00844.x | Test |
| Swamy GK, Simhan HN, Gammill HS, Heine RP. Clinical utility of fetal fibronectin for predicting preterm birth. J Reprod Med 2005;50:851–6 | Test |
| Tanir HM, Sener T, Yildiz Z. Cervicovaginal fetal fibronectin (FFN) for prediction of preterm delivery in symptomatic cases: a prospective study. Clin Exp Obstet Gynecol 2008;35:61–4 | Test |
| Tekesin I, Eberhart LH, Schaefer V, Wallwiener D, Schmidt S. Evaluation and validation of a new risk score (CLEOPATRA score) to predict the probability of premature delivery for patients with threatened preterm labor. Ultrasound Obstet Gynecol 2005;26:699–706. https://doi.org/10.1002/uog.2633 | Test |
| Tekesin I, Marek S, Hellmeyer L, Reitz D, Schmidt S. Assessment of rapid fetal fibronectin in predicting preterm delivery. Obstet Gynecol 2005;105:280–4 | Test |
| Tekesin I, Wallwiener D, Schmidt S. The value of quantitative ultrasound tissue characterization of the cervix and rapid fetal fibronectin in predicting preterm delivery. J Perinat Med 2005;33:383–91. https://doi.org/10.1515/JPM.2005.070 | Test |
| Triana H, Saldivar D, Contreras N, Guzman A, Soria A, Farran I, et al. Fetal Fibronectin in the Diagnosis of Preterm Labor. In Cabero L, Carrera JM, editors. Perinatology 2001 Volumes 1 and 2. Bologna: Monduzzi International Proceedings Division; 2001. pp. 599–602 | Test |
| Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor. Ultrasound Obstet Gynecol 2006;27:368–72. https://doi.org/10.1002/uog.2723 | Test |
| Tsoi E, Akmal S, Geerts L, Jeffery B, Nicolaides KH. Sonographic measurement of cervical length and fetal fibronectin testing in threatened preterm labor. Obstet Gynecol Surv 2006;61:441–2 | Test |
| Tsourapas A, Roberts T, Barton P, Honest H, Forbes C, Hyde C, et al. An economic evaluation of alternative test-intervention strategies to prevent spontaneous pre-term birth in singleton pregnancies (Structured abstract). Acta Obstetricia et Gynecologica Scandinavica 2009;88:1319–30. URL: http://onlinelibrary.wiley.com/o/cochrane/cleed/articles/NHSEED-22010000199/frame.html (accessed September 2017) | Test |
| van Baaren GJ, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, et al. Cost-effectiveness of diagnostic testing strategies including cervical length measurement and fibronectin testing in women with symptoms of preterm labor. Ultrasound Obstet Gynecol 2018;51:596–603 | Test |
| van Baaren G-J, Vis J, Wilms F, Oudijk M, Kwee A, Porath M, et al. The risk of preterm delivery in women with signs of preterm labor before 34 weeks who do not deliver within 7 days: the APOSTEL-1 cohort. Am J Obstet Gynecol 2014;210(Suppl. 1):S375 | Test |
| Voluménie JL, Guibourdenche J, Doridot V, Sibony O, Oury JF, Blot P, Luton D. Failure of cervical fibronectin to predict premature delivery in a population of monofetal pregnancies with idiopathic preterm labor. Eur J Obstet Gynecol Reprod Biol 2001;97:35–9 | Test |
| von Schöning D, Fischer T, von Tucher E, Slowinski T, Weichert A, Henrich W, Thomas A. Cervical sonoelastography for improving prediction of preterm birth compared with cervical length measurement and fetal fibronectin test. J Perinat Med 2015;43:531–6. https://doi.org/10.1515/jpm-2014-0356 | Test |
| Watson DL, Kim SJ, Humphrey MD. Study of cervicovaginal fetal fibronectin status to guide treatment of threatened preterm labour. Aust N Z J Obstet Gynaecol 1998;38:185–7 | Test |
| Watson HA, Carter J, Seed PT, Tribe RM, Shennan AH. The QUIPP app: a safe alternative to a treat-all strategy for threatened preterm labour. Ultrasound Obstet Gynecol 2017:24 | Test |
| Wilms FF, van Baaren GJ, Vis JY, Oudijk MA, Kwee A, Porath MM, et al. Prescribing patterns of antenatal corticosteroids in women with threatened preterm labor. Eur J Obstet Gynecol Reprod Biol 2015;192:47–53 https://doi.org/10.1016/j.ejogrb.2015.06.008 | Test |
| Wilms FF, Vis JY, de Wit-Zuurendonk L, Porath MM, Mol BW. What is the risk of preterm delivery after arrested preterm labor? Am J Perinatol 2015;32:63–70. https://doi.org/10.1055/s-0034-1374818 | Test |
| Woodworth A, Moore J, G’Sell C, Verdoes A, Snyder JA, Morris L, et al. Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-6: albumin ratio as markers of preterm delivery. Clin Chem 2007;53:1534–40 | Test |
| Yoneda S, Sakai M, Sasaki Y, Shiozaki A, Hidaka T, Saito S. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes. J Obstet Gynaecol Res 2007;33:38–44 | Test |
| Yoneda S, Shiozaki A, Yoneda N, Shima T, Ito M, Yamanaka M, et al. Prediction of exact delivery time in patients with preterm labor and intact membranes at admission by amniotic fluid interleukin-8 level and preterm labor index. J Obstet Gynaecol Res 2011;37:861–6. https://doi.org/10.1111/j.1447-0756.2010.01453.x | Test |
| Yoneyama K, Kimura A, Kogo M, Kiuchi Y, Morimoto T, Okai T. Clinical predictive factors for preterm birth in women with threatened preterm labour or preterm premature ruptured membranes? Aust N Z J Obstet Gynaecol 2009;49:16–21 | Test |
| Magro-Malosso E, Seravalli V, Cozzolino M, Spitaleri M, Susini T, Di Tommaso M. Prediction of preterm delivery by fetal fibronectin in symptomatic and asymptomatic women with cervical length ≤ 20 mm. J Matern Fetal Neonatal Med 2017;30:294–7. https://doi.org/10.3109/14767058.2016.1171309 | Test |
| Management of preterm labour. Volume 1: Evidence report and appendices; Volume 2: Evidence tables (Structured abstract). Health Technol Assess 2000;1(4). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32001000946/frame.html (accessed September 2017) | Unobtainable |
| Fetal fibronectin for the prediction of preterm labor (Structured abstract). Health Technol Assess 2000(4). | Unobtainable |
| Fetal fibronectin point of care test (project record). Health Technol Assess 2006(2). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32006000075/frame.html | Unobtainable |
| Actim Partus test (project record). Health Technol Assess 2010(4). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32010001243/frame.html | Unobtainable |
| Aboulenien W, Azzam A, Saleh F, Abollo M, Soliman A. Insulin-like growth factor binding protein-1 in cervico-vaginal secretions as an indicator of premature rupture of membranes: Comparison with nitrazine test and amniotic fluid index. Int J Gynecol Obstet 2009;107:S413 | Unobtainable |
| American College of Obstetricians and Gynecologists. Fetal fibronectin preterm labor risk test. Int J Gynecol Obstet 1997;59:164 | Unobtainable |
| Anonymous. Fetal fibronectin measurement to predict preterm delivery. Am Fam Physician 1992;45:287 | Unobtainable |
| Bare T, Mitre A, Vata E, Shkurti E, Hoxhaj O, Manoku N. Biomarkers and cervical length to predict spontaneous preterm birth in high-risk women. IJEES 2015;5:29–34 | Unobtainable |
| Basak S, Babbur V. Audit of in-utero transfers following introduction of rapid fetal fibronectin test for assessment of preterm labour in a district general hospital in United Kingdom. Int J Gynecol Obstet 2012;119:S291 | Unobtainable |
| Bertani D, Beski L, Tagliavini M, Benassi L. Prognostic Role of Fetal Fibronectin in Threatened Preterm Delivery. Merialdi A, Cavatorta E, Gramellini D, editors. Parma: 18th Meeting on Prenatal Medicine; 1993 | Unobtainable |
| Bianco M, Depew C, Meisel R. A fetal fibronectin assay for detection of rupture of membranes. Am J Obstet Gynecol 1993;168:435 | Unobtainable |
| Burwick R, York N, Lee, Ross M, Kjos S. Cervilenz assessment of cervical length is equivalent to fetal fibronectin in the prediction of preterm delivery. American College of Obstetricians and Gynecologists’ Annual Meeting, San Francisco, CA, 17–19 May 2010. URL: http://onlinelibrary.wiley.com/o/cochrane/clcentral/articles/741/CN-00755741/frame.html (accessed September 2017) | Unobtainable |
| Crane J, Armson BA, Dodds L, Kennedy W, Feinberg R. Predictors of preterm delivery. Am J Obstet Gynecol 1998;178:S189 | Unobtainable |
| Gervasi MT, Marsoni V, Reveane A, Serra MM, Bracalente G, Darin G. Role of Fetal Fibronectin in the Diagnosis of Preterm Delivery. Cosmi EV, editor. Spoleto: 6th National Congress–Societa Italiana Di Medicina Perinatale; 1996 | Unobtainable |
| Ghidini A, Poggi SH, Korker V. Perfomance of vaginal fetal fibronectin as predictor of preterm delivery in a community hospital. J Soc Gynecol Investig 2006;13:338A-A | Unobtainable |
| Gottschalk EM, Wenzel S, Salomon NS, Dudenhausen JW, Henrich W. Importance of cervical length measurement and fetal Fibronectin (fFN) to the prediction of lower premature birth rate. Geburtshilfe Und Frauenheilkunde 2008;68:S25-S | Unobtainable |
| Hayes, Inc. Fetal fibronectin test in women with symptoms of preterm labor (Structured abstract). Health Technol Assess 2006(4). URL: http://onlinelibrary.wiley.com/o/cochrane/clhta/articles/HTA-32006001571/frame.html (accessed September 2017) | Unobtainable |
| Klee GG, Arnold SE, Heise RH. Fetal fibronectin as a risk predictor of preterm delivery. Clinical Chemistry 2000;46:A65-A | Unobtainable |
| Lu GC, Goldenberg RL, Cliver SP, Kreaden US, Andrews WW. Quantitative fetal fibronectin levels and the prediction of spontaneous preterm birth in symptomatic women. Am J Obstet Gynecol 2000;182:S53 | Unobtainable |
| Luzzi VI, Hankins K, Gronowski AM. Predictive value of fetal fibronectin as a biochemical marker of preterm delivery using the rapid fFN TLiTM system. Clinical Chemistry 2002;48:A121-A | Unobtainable |
| Macones GA, Stamilio D. Fetal fibronectin testing: the cost for false negative/positive results across gestational ages. Am J Obstet Gynecol 2000;182:S46 | Unobtainable |
| Marzolf G, Kreaden U, Lockhart T, Cooper M, Paulson M, Sheldon L, et al. Effect of time delay between specimen collection and testing with rapid fetal fibronectin (fFN) for the Adeza TLi (TM) System. Clinical Chemistry 1999;45:A94-A | Unobtainable |
| Mims O, Taylor S, Sundaram S, Stevens M, Manimekalai S, Goldstein PJ. Fetal fibronectin assay to predict pre term labor. Clinical Chemistry 1999;45:A72-A | Unobtainable |
| Min DL, Haberman S, McCalla S. The impact of the rapid fetal fibronectin assay on the management of preterm labor. Obstetrics and Gynecology 2004;103:73S-S | Unobtainable |
| Morgan BR. Clinical performance of the Adeza biomedical TLi Rapid Fetal Fibronectin Test at a multispecialty clinic. Clinical Chemistry 2001;47:A145-A | Unobtainable |
| Nishida N, Asakura H, Yonezawa M, Tateyama N, Doi D, Fukami T. Prediction of preterm birth in comparison of TVS findings to those with positive fetal fibronectin (fFN). Int J Gynecol Obstet 2009;107:S468 | Unobtainable |
| Oyelese Y, Peters S, Ananth CV, Kinzler W, Smulian JC. The utility of fetal fibronectin in predicting preterm birth in clinical practice. J Soc Gynecol Investig 2006;13:123A-A | Unobtainable |
| Paternoster DM, Lazzarin L, Stella A, Pignataro R. Fetal Fibronectin and Determination of Blood Ferritin Levels in Preterm Delivery. Cosmi EV, editor. Spoleto: 6th National Congress–Societa Italiana Di Medicina Perinatale; 1996 | Unobtainable |
| Pates JA, Lattu AL, Nielsen PE. The value of fetal fibronectin in predicting the onset of labor before 41 weeks of gestation. Obstetrics and Gynecology 2008;111:102S-S | Unobtainable |
| Paulson MC, Lapointe J, Sheldon E, Mason R, Hernandez O. Elimination of sample warming for rapid fFN testing. Clinical Chemistry 2002;48:A194-A | Unobtainable |
| Paulson MC, Sheldon EL. A Comparison of rapid fFN for the TLi system and the rapid fFN for the TLi IQ system. Clinical Chemistry 2001;47:A111-A | Unobtainable |
| Quintieri F, Paternoster D, Depaoli M, Grella PV, Plebani M. Fetal Fibronectin in Early Diagnosis of Preterm Births. Merialdi A, Cavatorta E, Gramellini D, editors. Parma: 18th Meeting on Prenatal Medicine; 1993 | Unobtainable |
| Ray D, Dyson D, Hendershott C, Field R, Walton D, Newman L, et al. A comparison of rapid fFN on the TLiTM system to the fFN enzyme immunoassay in symptomatic women. Am J Obstet Gynecol 2000;182:S44 | Unobtainable |
| Reveane A, Marsoni V, Gervasi MT, Amici G, Serra M, Marzolini M. Correlation between fetal fibronectin levels and the risk of premature delivery. Cosmi EV, editor. Spoleto: 6th National Congress–Societa Italiana Di Medicina Perinatale; 1996 | Unobtainable |
| Rinehart BK, Terrone DA, Isler CM, Barrilleaux PS, Bufkin LK, Morrison JC. Patients with false labor symptoms and positive fetal fibronectin are more likely to deliver preterm. Am J Obstet Gynecol 2000;182:S49 | Unobtainable |
| Sheldon EL, Paulson MC, Hernandez O. The effect of yeast on rapid fFN for the TLi(tm) system. Clinical Chemistry 2001;47:A184-A | Unobtainable |
| Sheldon EL, Paulson MC, Lockhart T, Marzolf G. Analytical evaluation of Rapid Fetal Fibronectin (fFN) for the Adeza Tli((TM)) System. Clinical Chemistry 2000;46:A4-A | Unobtainable |
| Siddiqa M, Haloob R. An audit of fetal fibronectin test. Int J Gynecol Obstet 2012;119:S752 | Unobtainable |
| Volpogni C, Facchinetti F, Martinez F, Genazzani AR. Fetal Fibronectin as Predictor of Preterm Birth. In Merialdi A, Cavatorta E, Gramellini D, editors. Parma: 18th Meeting on Prenatal Medicine; 1993 | Unobtainable |
